Damien Soghoian
Venture Partner at Foresite Labs
San Francisco Bay Area
Overview
Work Experience
Venture Partner
2024 - Current
Foresite Labs is a biotechnology company.
Health Security Advisor
2023
Managing Director
2022 - 2023
Global Health Investment Corporation ccelerates the development of technologies that improve human health around the world.
Director
2018 - 2022
Foresite Capital is a healthcare and life sciences investment firm.
Head of Strategy and Operations
2018 - 2022
Foresite Labs is a biotechnology company.
Fellow, Ending Bioweapons Programs
2020 - 2021
Science Lead, Project Baseline Study
2017 - 2018
Project Baseline is a broad effort designed to develop a well-defined reference, or "baseline," of good health as well as a rich data platform that may be used to better understand the transition from health to disease and identify additional risk factors for disease.
Senior Scientist, Immunology Technical Lead, Immunoscape Platform
2014 - 2018
Verily is pursuing research in systems biology, nanotechnology, and biomedical systems engineering, with potential applications for immuno-oncology and other areas. We combine experimental capabilities with computational biology to support data generation and analysis across our clinical programs.
Verily is an Alphabet health tech company focused on research, care, and health financing to deliver on the promise of precision health.
Raised $3,500,000,000.00 from Swiss Re Corporate Solutions.
Scientist
2014 - 2016
Google[x], Google Life Sciences
Google is a multinational corporation that specializes in Internet-related services and organizes the world’s information.
Raised $26,100,000.00 from Angel Investors LP, Kleiner Perkins, Signatures Capital, Sequoia Capital, Arnold Schwarzenegger, Shaquille O'Neal, Henry Kissinger, Google and Tiger Woods.
Graduate Student
2010 - 2014
PI: Bruce Walker - Human immune profiling - CD4 and CD8 immunology - Anti-viral and vaccine immune responses - CyTOF (mass cytometry) and other high-dimensional technologies
Graduate Student
2009 - 2014
Researcher
2004 - 2007
PI: Pamela Bjorkman